awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39369141-7307F6C8-F67A-43EE-89BE-46C3C45819F9
Q39369141-7307F6C8-F67A-43EE-89BE-46C3C45819F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39369141-7307F6C8-F67A-43EE-89BE-46C3C45819F9
Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer.
P2860
Q39369141-7307F6C8-F67A-43EE-89BE-46C3C45819F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39369141-7307F6C8-F67A-43EE-89BE-46C3C45819F9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5e52fa1914f450dde7198cb766b86427ff52e83
P2860
A phase II study of imatinib in patients with advanced anaplastic thyroid cancer.